Found 5 matching trials
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
PHASE2This is a two-part open label, non-randomized, Phase 2, study of ZEN003694 ...
Location
Banner MD Anderson Cancer Center
A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma
PHASE2This study is a multicenter, prospective, single-arm Phase II clinical tria...
Location
Shanghai East Hospital
A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI
PHASE2This study is a prospective, open-label, phase II clinical trial, aiming to...
Location
Fudan University Shanghai Cancer Center
Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids
N/AA case-control study was conducted to evaluate the efficacy and mechanism o...
Location
The First Affiliated Hospital of Guangzhou Medical University
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
PHASE2This study aims to evaluate the efficacy and safety of DS-1062a in particip...
Status
Active Not Recruiting
Location
Institut Bergonié